The case for a Gold Box
Wonder if there is a chance to remove black box warning as a result of current sNDA review. Wonder if management has asked about this or made a case for it. These are standard for antipsychotics, but Nuplazid is not a typical antipsychotic and may actually present a reduced mortality rate. And there is more evidence for the sterling safety profile every day.
Seems like it should be a Gold Box, not a black one!